SCHEMBL7216455

SCHEMBL7216455

[CH2]Cc1nc2c(F)cccc2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.58
RAB9A P51151 7/20 0.56
GAA P10253 7/20 0.56
NPC1 O15118 6/20 0.56
ALDH1A1 P00352 5/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
KDM4E B2RXH2 5/20 0.56
HPGD P15428 4/20 0.56
LMNA P02545 4/20 0.56
PRNP P04156 1/20 0.56
MAPT P10636 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.49
CASP3 P42574 2/20 0.47
SENP8 Q96LD8 2/20 0.47
SENP7 Q9BQF6 2/20 0.47
SENP6 Q9GZR1 2/20 0.47
MAPK1 P28482 1/20 0.47
TSHR P16473 1/20 0.47
HTR2C P28335 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7218454 0.84 SMN1; SMN2 (0.56) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL28478793 0.84 SMN1; SMN2 (0.56) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL21954228 0.84 SMN1; SMN2 (0.61) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL27940612 0.83 SMN1; SMN2 (0.51) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL1927918 0.82 SMN1; SMN2 (0.59) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL14127136 0.80 ALDH1A1 (0.56) RAB9AGAAALDH1A1MEN1KMT2A
SCHEMBL27690906 0.80 LMNA (0.56) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL27349702 0.80 SMN1; SMN2 (0.51) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL102576 0.77 SMN1; SMN2 (0.49) SMN1; SMN2RAB9AGAANPC1ALDH1A1
SCHEMBL7698118 0.77 SMN1; SMN2 (0.61) SMN1; SMN2RAB9AGAANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1193020-C Process for preparing amic acid esters IHARA CHEMICAL IND CO (JP) 2005-03-16 CN disclosed
US-6576765-B2 Process for preparing amic acid esters IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-06-10 US disclosed
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-02-13 US disclosed
CN-1366523-A Process for preparing amic acid esters IHARA CHEMICAL IND CO (JP) 2002-08-28 CN disclosed
EP-1182199-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS MCCC2, EMC1, GANC SMN1; SMN2 4168/4885RAB9A 774/4885GAA 853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.